Abstract

REPORT ON THE STUDY OF NOVEL APPROACHES, TECHNICAL CONSIDERATION AND SUPPORT IN THE TREATMENT THERAPY AND PANDEMIC INFECTION PREPAREDNESS FOR THE RECENT EPIDEMIC OUTBREAK OF SARS-CoV-2 INFECTION, COVID-19 DISEASE AND PANDEMIC MANAGEMENT INCLUDING CLINICAL

Saurabh Dilip Bhandare*

Abstract

In this recent outbreak of an epidemic infection-COVID-19 caused by SARS-CoV-2, which led to have caused pandemic that had begun in the years (December 2019), 2019. First it had started or it had emerged into the city of Wuhan and then in a time period had spread rapidly throughout the China. In the early December; 2019, the first case of pneumonia was observed from an unknown origin and was identified to be emerged in the city of Wuhan, the capital city of Hubei province; in the China. The pathogen was identified to be as a novel enveloped RNA beta corona virus, that is SARS-CoV-2, which had caused varying degrees of illness in patients; those are: often found to be diagnosed with symptoms such as: conjunction, congestion, nasal congestion, headache, cough, sore throat, sputum production, fatigue, haemoptysis, shortness of breath, nausea or vomiting, diarrhoea, myalgia or arthralgia, chills etc. that is caused by the infection of COVID-19-SARS-CoV-2 a disease causing agent or pathogen, which is a mammalian virus, termed SARS/MERS- Severe acute respiratory syndrome, middle east respiratory syndrome; are zoonotic. The term novel corona virus is most significant in the recent study practices about the pandemic/pandemics. (nCoV).

Keywords: SARS-CoV-2-COVID-19-Pandemic or epidemic, U.S.FDA, U.K.MHRA, Emergency medication-primary care, viral infection and global health-pandemic preparedness.